This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Simula MP, Marktel S, Fozza C, Kaeda J, Szydlo RM, Nadal E et al. Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy. Leukemia 2007; 21: 943–948.
Kalhs P, Schwarzinger I, Anderson G, Mori M, Clift RA, Storb R et al. A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia. Blood 1995; 86: 2028–2032.
Baughan ASJ, Worsley AM, McCarthy DM, Hows JM, Catovsky D, Gordon-Smith EC et al. Haematological reconstitution and severity of graft-versus-host disease after bone marrow transplantation for chronic granulocytic leukaemia: the influence of previous splenectomy. Br J Haematol 1984; 56: 445–454.
Gratwohl A, Hermans J, von Biezen A, Arcese W, de Witte T, Debusscher L et al. No advantage for patients who receive splenic irradiation before bone marrow transplantation for chronic myeloid leukemia: results of a prospective randomized study. Bone Marrow Transplant 1992; 10: 147–152.
Giralt S, Hester J, Huh Y, Hirsch-Ginsberg C, Rondon G, Seong D et al. CD8-depleted donor lymphocyte infusion as treatment for relapse in chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood 1995; 86: 4337–4343.
Jiang YZ, Barret J . Allogeneic CD4+ T cell-mediated graft-versus leukemia effect. Leuk Lymphoma 1997; 28: 33–42.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Uckan-Çetinkaya, D., Unal, S., Çetin, M. et al. Splenectomy status of the patient may have impact on response to donor lymphocyte infusions. Leukemia 21, 2049–2050 (2007). https://doi.org/10.1038/sj.leu.2404803
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404803